Skip to main content
Top
Published in: Arthritis Research & Therapy 6/2012

Open Access 01-12-2012 | Research article

Excessive bone formation in a mouse model of ankylosing spondylitis is associated with decreases in Wnt pathway inhibitors

Authors: Katelin R Haynes, Allison R Pettit, Ran Duan, Hsu-Wen Tseng, Tibor T Glant, Matthew A Brown, Gethin P Thomas

Published in: Arthritis Research & Therapy | Issue 6/2012

Login to get access

Abstract

Introduction

Ankylosing spondylitis (AS) is unique in its pathology where inflammation commences at the entheses before progressing to an osteoproliferative phenotype generating excessive bone formation that can result in joint fusion. The underlying mechanisms of this progression are poorly understood. Recent work has suggested that changes in Wnt signalling, a key bone regulatory pathway, may contribute to joint ankylosis in AS. Using the proteoglycan-induced spondylitis (PGISp) mouse model which displays spondylitis and eventual joint fusion following an initial inflammatory stimulus, we have characterised the structural and molecular changes that underlie disease progression.

Methods

PGISp mice were characterised 12 weeks after initiation of inflammation using histology, immunohistochemistry (IHC) and expression profiling.

Results

Inflammation initiated at the periphery of the intervertebral discs progressing to disc destruction followed by massively excessive cartilage and bone matrix formation, as demonstrated by toluidine blue staining and IHC for collagen type I and osteocalcin, leading to syndesmophyte formation. Expression levels of DKK1 and SOST, Wnt signalling inhibitors highly expressed in joints, were reduced by 49% and 63% respectively in the spine PGISp compared with control mice (P < 0.05) with SOST inhibition confirmed by IHC. Microarray profiling showed genes involved in inflammation and immune-regulation were altered. Further, a number of genes specifically involved in bone regulation including other members of the Wnt pathway were also dysregulated.

Conclusions

This study implicates the Wnt pathway as a likely mediator of the mechanism by which inflammation induces bony ankylosis in spondyloarthritis, raising the potential that therapies targeting this pathway may be effective in preventing this process.
Appendix
Available only for authorised users
Literature
1.
go back to reference Ronneberger M, Schett G: Pathophysiology of Spondyloarthritis. Current Rheumatology Reports. 2011, 1-5. Ronneberger M, Schett G: Pathophysiology of Spondyloarthritis. Current Rheumatology Reports. 2011, 1-5.
2.
go back to reference Appel H, Loddenkemper C, Miossec P: Rheumatoid arthritis and ankylosing spondylitis - pathology of acute inflammation. Clin Exp Rheumatol. 2009, 27: S15-19.PubMed Appel H, Loddenkemper C, Miossec P: Rheumatoid arthritis and ankylosing spondylitis - pathology of acute inflammation. Clin Exp Rheumatol. 2009, 27: S15-19.PubMed
3.
go back to reference Maksymowych WP: Disease modification in ankylosing spondylitis. Nat Rev Rheumatol. 2010, 6: 75-81. 10.1038/nrrheum.2009.258.CrossRefPubMed Maksymowych WP: Disease modification in ankylosing spondylitis. Nat Rev Rheumatol. 2010, 6: 75-81. 10.1038/nrrheum.2009.258.CrossRefPubMed
4.
go back to reference Maksymowych WP, Chiowchanwisawakit P, Clare T, Pedersen SJ, Ostergaard M, Lambert RG: Inflammatory lesions of the spine on magnetic resonance imaging predict the development of new syndesmophytes in ankylosing spondylitis: evidence of a relationship between inflammation and new bone formation. Arthritis Rheum. 2009, 60: 93-102. 10.1002/art.24132.CrossRefPubMed Maksymowych WP, Chiowchanwisawakit P, Clare T, Pedersen SJ, Ostergaard M, Lambert RG: Inflammatory lesions of the spine on magnetic resonance imaging predict the development of new syndesmophytes in ankylosing spondylitis: evidence of a relationship between inflammation and new bone formation. Arthritis Rheum. 2009, 60: 93-102. 10.1002/art.24132.CrossRefPubMed
5.
go back to reference Pedersen SJ, Sørensen IJ, Lambert RGW, Hermann K-GA, Garnero P, Johansen JS, Madsen OR, Hansen A, Hansen MS, Thamsborg G, Andersen LS, Majgaard O, Loft AG, Erlendsson J, Asmussen KH, Jurik AG, Møller J, Hasselquist M, Mikkelsen D, Østergaard M: Radiographic progression is associated with resolution of systemic inflammation in patients with axial spondylarthritis treated with tumor necrosis factor α inhibitors: a study of radiographic progression, inflammation on magnetic resonance imaging, and circulating biomarkers of inflammation, angiogenesis, and cartilage and bone turnover. Arthritis Rheum. 2011, 63: 3789-3800. 10.1002/art.30627.CrossRefPubMed Pedersen SJ, Sørensen IJ, Lambert RGW, Hermann K-GA, Garnero P, Johansen JS, Madsen OR, Hansen A, Hansen MS, Thamsborg G, Andersen LS, Majgaard O, Loft AG, Erlendsson J, Asmussen KH, Jurik AG, Møller J, Hasselquist M, Mikkelsen D, Østergaard M: Radiographic progression is associated with resolution of systemic inflammation in patients with axial spondylarthritis treated with tumor necrosis factor α inhibitors: a study of radiographic progression, inflammation on magnetic resonance imaging, and circulating biomarkers of inflammation, angiogenesis, and cartilage and bone turnover. Arthritis Rheum. 2011, 63: 3789-3800. 10.1002/art.30627.CrossRefPubMed
6.
go back to reference Hammer RE, Maika SD, Richardson JA, Tang J-P, Taurog JD: Spontaneous inflammatory disease in transgenic rats expressing HLA-B27 and human [beta]2m: An animal model of HLA-B27-associated human disorders. Cell. 1990, 63: 1099-1112. 10.1016/0092-8674(90)90512-D.CrossRefPubMed Hammer RE, Maika SD, Richardson JA, Tang J-P, Taurog JD: Spontaneous inflammatory disease in transgenic rats expressing HLA-B27 and human [beta]2m: An animal model of HLA-B27-associated human disorders. Cell. 1990, 63: 1099-1112. 10.1016/0092-8674(90)90512-D.CrossRefPubMed
7.
go back to reference Tran TM, Dorris ML, Satumtira N, Richardson JA, Hammer RE, Shang J, Taurog JD: Additional human beta-microglobulin curbs HLA-B27 misfolding and promotes arthritis and spondylitis without colitis in male HLA-B27-transgenic rats. Arthritis Rheum. 2006, 54: 1317-1327. 10.1002/art.21740.CrossRefPubMed Tran TM, Dorris ML, Satumtira N, Richardson JA, Hammer RE, Shang J, Taurog JD: Additional human beta-microglobulin curbs HLA-B27 misfolding and promotes arthritis and spondylitis without colitis in male HLA-B27-transgenic rats. Arthritis Rheum. 2006, 54: 1317-1327. 10.1002/art.21740.CrossRefPubMed
8.
go back to reference Redlich K, Gortz B, Hayer S, Zwerina J, Kollias G, Steiner G, Smolen JS, Schett G: Overexpression of tumor necrosis factor causes bilateral sacroiliitis. Arthritis Rheum. 2004, 50: 1001-1005. 10.1002/art.20194.CrossRefPubMed Redlich K, Gortz B, Hayer S, Zwerina J, Kollias G, Steiner G, Smolen JS, Schett G: Overexpression of tumor necrosis factor causes bilateral sacroiliitis. Arthritis Rheum. 2004, 50: 1001-1005. 10.1002/art.20194.CrossRefPubMed
9.
go back to reference Kontoyiannis D, Pasparakis M, Pizarro TT, Cominelli F, Kollias G: Impaired On/Off Regulation of TNF Biosynthesis in Mice Lacking TNF AU-Rich Elements: Implications for Joint and Gut-Associated Immunopathologies. Immunity. 1999, 10: 387-398. 10.1016/S1074-7613(00)80038-2.CrossRefPubMed Kontoyiannis D, Pasparakis M, Pizarro TT, Cominelli F, Kollias G: Impaired On/Off Regulation of TNF Biosynthesis in Mice Lacking TNF AU-Rich Elements: Implications for Joint and Gut-Associated Immunopathologies. Immunity. 1999, 10: 387-398. 10.1016/S1074-7613(00)80038-2.CrossRefPubMed
10.
go back to reference Capková J, Ivanyi P: H-2 influence on ankylosing enthesopathy of the ankle (ANKENT). Folia Biologica. 1992, 38: 258-262.PubMed Capková J, Ivanyi P: H-2 influence on ankylosing enthesopathy of the ankle (ANKENT). Folia Biologica. 1992, 38: 258-262.PubMed
11.
go back to reference Lories RJU, Matthys P, de Vlam K, Derese I, Luyten FP: Ankylosing enthesitis, dactylitis, and onychoperiostitis in male DBA/1 mice: a model of psoriatic arthritis. Ann Rheum Dis. 2004, 63: 595-598. 10.1136/ard.2003.013599.PubMedCentralCrossRefPubMed Lories RJU, Matthys P, de Vlam K, Derese I, Luyten FP: Ankylosing enthesitis, dactylitis, and onychoperiostitis in male DBA/1 mice: a model of psoriatic arthritis. Ann Rheum Dis. 2004, 63: 595-598. 10.1136/ard.2003.013599.PubMedCentralCrossRefPubMed
12.
go back to reference Glant TT, Mikecz K, Arzoumanian A, Poole AR: Proteoglycan-induced arthritis in BALB/c mice. Clinical features and histopathology. Arthritis Rheum. 1987, 30: 201-212. 10.1002/art.1780300211.CrossRefPubMed Glant TT, Mikecz K, Arzoumanian A, Poole AR: Proteoglycan-induced arthritis in BALB/c mice. Clinical features and histopathology. Arthritis Rheum. 1987, 30: 201-212. 10.1002/art.1780300211.CrossRefPubMed
13.
go back to reference Bardos T, Szabo Z, Czipri M, Vermes C, Tunyogi-Csapo M, Urban RM, Mikecz K, Glant TT: A longitudinal study on an autoimmune murine model of ankylosing spondylitis. Ann Rheum Dis. 2005, 64: 981-987. 10.1136/ard.2004.029710.PubMedCentralCrossRefPubMed Bardos T, Szabo Z, Czipri M, Vermes C, Tunyogi-Csapo M, Urban RM, Mikecz K, Glant TT: A longitudinal study on an autoimmune murine model of ankylosing spondylitis. Ann Rheum Dis. 2005, 64: 981-987. 10.1136/ard.2004.029710.PubMedCentralCrossRefPubMed
14.
go back to reference Baron R, Rawadi G: Targeting the Wnt/β-catenin pathway to regulate bone formation in the adult skeleton. Endocrinology. 2007, 148: 2635-2643. 10.1210/en.2007-0270.CrossRefPubMed Baron R, Rawadi G: Targeting the Wnt/β-catenin pathway to regulate bone formation in the adult skeleton. Endocrinology. 2007, 148: 2635-2643. 10.1210/en.2007-0270.CrossRefPubMed
15.
go back to reference Daoussis D, Liossis SN, Solomou EE, Tsanaktsi A, Bounia K, Karampetsou M, Yiannopoulos G, Andonopoulos AP: Evidence that Dkk-1 is dysfunctional in ankylosing spondylitis. Arthritis Rheum. 2010, 62: 150-158. 10.1002/art.27231.CrossRefPubMed Daoussis D, Liossis SN, Solomou EE, Tsanaktsi A, Bounia K, Karampetsou M, Yiannopoulos G, Andonopoulos AP: Evidence that Dkk-1 is dysfunctional in ankylosing spondylitis. Arthritis Rheum. 2010, 62: 150-158. 10.1002/art.27231.CrossRefPubMed
16.
go back to reference Diarra D, Stolina M, Polzer K, Zwerina J, Ominsky MS, Dwyer D, Korb A, Smolen J, Hoffmann M, Scheinecker C, van der Heide D, Landewe R, Lacey D, Richards WG, Schett G: Dickkopf-1 is a master regulator of joint remodeling. Nature Medicine. 2007, 13: 156-163. 10.1038/nm1538.CrossRefPubMed Diarra D, Stolina M, Polzer K, Zwerina J, Ominsky MS, Dwyer D, Korb A, Smolen J, Hoffmann M, Scheinecker C, van der Heide D, Landewe R, Lacey D, Richards WG, Schett G: Dickkopf-1 is a master regulator of joint remodeling. Nature Medicine. 2007, 13: 156-163. 10.1038/nm1538.CrossRefPubMed
17.
go back to reference Uderhardt S, Diarra D, Katzenbeisser J, David J-P, Zwerina J, Richards WG, Kronke G, Schett G: Blockade of Dickkopf-1 induces fusion of sacroiliac joints. Ann Rheum Dis. 2010, 69: 592-597. 10.1136/ard.2008.102046.CrossRefPubMed Uderhardt S, Diarra D, Katzenbeisser J, David J-P, Zwerina J, Richards WG, Kronke G, Schett G: Blockade of Dickkopf-1 induces fusion of sacroiliac joints. Ann Rheum Dis. 2010, 69: 592-597. 10.1136/ard.2008.102046.CrossRefPubMed
18.
go back to reference Finnegan A, Grusby MJ, Kaplan CD, O'Neill SK, Eibel H, Koreny T, Czipri M, Mikecz K, Zhang J: IL-4 and IL-12 Regulate proteoglycan-induced arthritis through stat-dependent mechanisms. J Immunol. 2002, 169: 3345-3352.CrossRefPubMed Finnegan A, Grusby MJ, Kaplan CD, O'Neill SK, Eibel H, Koreny T, Czipri M, Mikecz K, Zhang J: IL-4 and IL-12 Regulate proteoglycan-induced arthritis through stat-dependent mechanisms. J Immunol. 2002, 169: 3345-3352.CrossRefPubMed
19.
go back to reference Gruber HE, Ingram J, Hanley EN: An improved staining method for intervertebral disc tissue. Biotech Histochem. 2002, 77: 81-83.CrossRefPubMed Gruber HE, Ingram J, Hanley EN: An improved staining method for intervertebral disc tissue. Biotech Histochem. 2002, 77: 81-83.CrossRefPubMed
20.
go back to reference Chang MK, Raggatt L-J, Alexander KA, Kuliwaba JS, Fazzalari NL, Schroder K, Maylin ER, Ripoll VM, Hume DA, Pettit AR: Osteal tissue macrophages are intercalated throughout human and mouse bone lining tissues and regulate osteoblast function in vitro and in vivo. The J Immunol. 2008, 181: 1232-1244.CrossRefPubMed Chang MK, Raggatt L-J, Alexander KA, Kuliwaba JS, Fazzalari NL, Schroder K, Maylin ER, Ripoll VM, Hume DA, Pettit AR: Osteal tissue macrophages are intercalated throughout human and mouse bone lining tissues and regulate osteoblast function in vitro and in vivo. The J Immunol. 2008, 181: 1232-1244.CrossRefPubMed
21.
go back to reference Walsh NC, Reinwald S, Manning CA, Condon KW, Iwata K, Burr DB, Gravallese EM: Osteoblast function is compromised at sites of focal bone erosion in inflammatory arthritis. J Bone Miner Res. 2009, 24: 1572-1585. 10.1359/jbmr.090320.CrossRefPubMed Walsh NC, Reinwald S, Manning CA, Condon KW, Iwata K, Burr DB, Gravallese EM: Osteoblast function is compromised at sites of focal bone erosion in inflammatory arthritis. J Bone Miner Res. 2009, 24: 1572-1585. 10.1359/jbmr.090320.CrossRefPubMed
22.
go back to reference Thomas G, Moffatt P, Salois P, Gaumond MH, Gingras R, Godin E, Miao D, Goltzman D, Lanctot C: Osteocrin, a novel bone-specific secreted protein that modulates the osteoblast phenotype. J Biol Chem. 2003, 278: 50563-50571. 10.1074/jbc.M307310200.CrossRefPubMed Thomas G, Moffatt P, Salois P, Gaumond MH, Gingras R, Godin E, Miao D, Goltzman D, Lanctot C: Osteocrin, a novel bone-specific secreted protein that modulates the osteoblast phenotype. J Biol Chem. 2003, 278: 50563-50571. 10.1074/jbc.M307310200.CrossRefPubMed
23.
go back to reference Duan R, Leo P, Bradbury L, Brown MA, Thomas G: Gene expression profiling reveals a downregulation in immune-associated genes in patients with AS. Ann Rheum Dis. 2010, 69: 1724-1729. 10.1136/ard.2009.111690.CrossRefPubMed Duan R, Leo P, Bradbury L, Brown MA, Thomas G: Gene expression profiling reveals a downregulation in immune-associated genes in patients with AS. Ann Rheum Dis. 2010, 69: 1724-1729. 10.1136/ard.2009.111690.CrossRefPubMed
24.
go back to reference Du P, Kibbe WA, Lin SM: lumi: a pipeline for processing Illumina microarray. Bioinformatics. 2008, 24: 1547-1548. 10.1093/bioinformatics/btn224.CrossRefPubMed Du P, Kibbe WA, Lin SM: lumi: a pipeline for processing Illumina microarray. Bioinformatics. 2008, 24: 1547-1548. 10.1093/bioinformatics/btn224.CrossRefPubMed
25.
go back to reference Simon R, Lam A, Ming-Chung L, Ngan M, Menenzes S, Zhao Y: Analysis of gene expression data using brb-array tools. Cancer Inform. 2007, 3: 11-17.PubMedCentralPubMed Simon R, Lam A, Ming-Chung L, Ngan M, Menenzes S, Zhao Y: Analysis of gene expression data using brb-array tools. Cancer Inform. 2007, 3: 11-17.PubMedCentralPubMed
26.
go back to reference Pimentel-Santos F, Ligeiro D, Matos M, Mourao A, Costa J, Santos H, Barcelos A, Godinho F, Pinto P, Cruz M, Fonseca J, Guedes-Pinto H, Branco J, Brown M, Thomas G: Whole blood transcriptional profiling in ankylosing spondylitis identifies novel candidate genes that might contribute to the inflammatory and tissue-destructive disease aspects. Arthritis Res Ther. 2011, 13: R57-10.1186/ar3309.PubMedCentralCrossRefPubMed Pimentel-Santos F, Ligeiro D, Matos M, Mourao A, Costa J, Santos H, Barcelos A, Godinho F, Pinto P, Cruz M, Fonseca J, Guedes-Pinto H, Branco J, Brown M, Thomas G: Whole blood transcriptional profiling in ankylosing spondylitis identifies novel candidate genes that might contribute to the inflammatory and tissue-destructive disease aspects. Arthritis Res Ther. 2011, 13: R57-10.1186/ar3309.PubMedCentralCrossRefPubMed
27.
go back to reference Calin A, Elswood J: The relationship between pelvic, spinal and hip involvement in ankylosing spondylitis-one disease process or several?. BrJ Rheumatol. 1988, 27: 393-395. 10.1093/rheumatology/27.5.393.CrossRef Calin A, Elswood J: The relationship between pelvic, spinal and hip involvement in ankylosing spondylitis-one disease process or several?. BrJ Rheumatol. 1988, 27: 393-395. 10.1093/rheumatology/27.5.393.CrossRef
28.
go back to reference Glant TT, Finnegan A, Mikecz K: Proteoglycan-induced arthritis: immune regulation, cellular mechanisms, and genetics. Crit Rev Immunol. 2003, 23: 199-250. 10.1615/CritRevImmunol.v23.i3.20.CrossRefPubMed Glant TT, Finnegan A, Mikecz K: Proteoglycan-induced arthritis: immune regulation, cellular mechanisms, and genetics. Crit Rev Immunol. 2003, 23: 199-250. 10.1615/CritRevImmunol.v23.i3.20.CrossRefPubMed
29.
go back to reference Benjamin M, McGonagle D: The enthesis organ concept and its relevance to the spondyloarthropathies. Adv Exp Med Biol. 2009, 649: 57-70. 10.1007/978-1-4419-0298-6_4.CrossRefPubMed Benjamin M, McGonagle D: The enthesis organ concept and its relevance to the spondyloarthropathies. Adv Exp Med Biol. 2009, 649: 57-70. 10.1007/978-1-4419-0298-6_4.CrossRefPubMed
30.
go back to reference Kabasakal Y, Garrett SL, Calin A: The epidemiology of spondylodiscitis in ankylosing spondylitis-a controlled study. Rheumatology. 1996, 35: 660-663. 10.1093/rheumatology/35.7.660.CrossRef Kabasakal Y, Garrett SL, Calin A: The epidemiology of spondylodiscitis in ankylosing spondylitis-a controlled study. Rheumatology. 1996, 35: 660-663. 10.1093/rheumatology/35.7.660.CrossRef
31.
go back to reference Cawley MI, Chalmers TM, Kellgren JH, Ball J: Destructive lesions of vertebral bodies in ankylosing spondylitis. Ann Rheum Dis. 1972, 31: 345-358. 10.1136/ard.31.5.345.PubMedCentralCrossRefPubMed Cawley MI, Chalmers TM, Kellgren JH, Ball J: Destructive lesions of vertebral bodies in ankylosing spondylitis. Ann Rheum Dis. 1972, 31: 345-358. 10.1136/ard.31.5.345.PubMedCentralCrossRefPubMed
32.
go back to reference van der Heijde D, Landewe R, Baraliakos X, Houben H, van Tubergen A, Williamson P, Xu W, Baker D, Goldstein N, Braun J: Radiographic findings following two years of infliximab therapy in patients with ankylosing spondylitis. Arthritis Rheum. 2008, 58: 3063-3070. 10.1002/art.23901.CrossRefPubMed van der Heijde D, Landewe R, Baraliakos X, Houben H, van Tubergen A, Williamson P, Xu W, Baker D, Goldstein N, Braun J: Radiographic findings following two years of infliximab therapy in patients with ankylosing spondylitis. Arthritis Rheum. 2008, 58: 3063-3070. 10.1002/art.23901.CrossRefPubMed
33.
go back to reference Lories RJU, Derese I, de Bari C, Luyten FP: Evidence for uncoupling of inflammation and joint remodeling in a mouse model of spondylarthritis. Arthritis Rheum. 2007, 56: 489-497. 10.1002/art.22372.CrossRefPubMed Lories RJU, Derese I, de Bari C, Luyten FP: Evidence for uncoupling of inflammation and joint remodeling in a mouse model of spondylarthritis. Arthritis Rheum. 2007, 56: 489-497. 10.1002/art.22372.CrossRefPubMed
34.
go back to reference Maksymowych WP, Landewé R, Conner-Spady B, Dougados M, Mielants H, van der Tempel H, Poole AR, Wang N, van der Heijde D: Serum matrix metalloproteinase 3 is an independent predictor of structural damage progression in patients with ankylosing spondylitis. Arthritis Rheum. 2007, 56: 1846-1853. 10.1002/art.22589.CrossRefPubMed Maksymowych WP, Landewé R, Conner-Spady B, Dougados M, Mielants H, van der Tempel H, Poole AR, Wang N, van der Heijde D: Serum matrix metalloproteinase 3 is an independent predictor of structural damage progression in patients with ankylosing spondylitis. Arthritis Rheum. 2007, 56: 1846-1853. 10.1002/art.22589.CrossRefPubMed
35.
go back to reference Raj PP: Intervertebral disc: anatomy-physiology-pathophysiology-treatment. Pain Practice. 2008, 8: 18-44. 10.1111/j.1533-2500.2007.00171.x.CrossRefPubMed Raj PP: Intervertebral disc: anatomy-physiology-pathophysiology-treatment. Pain Practice. 2008, 8: 18-44. 10.1111/j.1533-2500.2007.00171.x.CrossRefPubMed
36.
go back to reference Sims A-M, Timms AE, Bruges-Armas J, Burgos-Vargas R, Chou C-T, Doan T, Dowling A, Fialho RN, Gergely P, Gladman DD, Inman R, Kauppi M, Kaarela K, Laiho K, Maksymowych W, Pointon JJ, Rahman P, Reveille JD, Sorrentino R, Tuomilehto J, Vargas-Alarcon G, Wordsworth BP, Xu H, Brown MA, International Genetics of Ankylosing Spondylitis: Prospective meta-analysis of interleukin 1 gene complex polymorphisms confirms associations with ankylosing spondylitis. Ann Rheum Dis. 2008, 67: 1305-1309.CrossRefPubMed Sims A-M, Timms AE, Bruges-Armas J, Burgos-Vargas R, Chou C-T, Doan T, Dowling A, Fialho RN, Gergely P, Gladman DD, Inman R, Kauppi M, Kaarela K, Laiho K, Maksymowych W, Pointon JJ, Rahman P, Reveille JD, Sorrentino R, Tuomilehto J, Vargas-Alarcon G, Wordsworth BP, Xu H, Brown MA, International Genetics of Ankylosing Spondylitis: Prospective meta-analysis of interleukin 1 gene complex polymorphisms confirms associations with ankylosing spondylitis. Ann Rheum Dis. 2008, 67: 1305-1309.CrossRefPubMed
37.
go back to reference Evans DM, Spencer CC, Pointon JJ, Su Z, Harvey D, Kochan G, Opperman U, Dilthey A, Pirinen M, Stone MA, Appleton L, Moutsianis L, Leslie S, Wordsworth T, Kenna TJ, Karaderi T, Thomas GP, Ward MM, Weisman MH, Farrar C, Bradbury LA, Danoy P, Inman RD, Maksymowych W, Gladman D, Rahman P, Morgan A, Marzo-Ortega H, Bowness P, Gaffney K, et al: Interaction between ERAP1 and HLA-B27 in ankylosing spondylitis implicates peptide handling in the mechanism for HLA-B27 in disease susceptibility. Nat Genet. 2011, 43: 761-767. 10.1038/ng.873.PubMedCentralCrossRefPubMed Evans DM, Spencer CC, Pointon JJ, Su Z, Harvey D, Kochan G, Opperman U, Dilthey A, Pirinen M, Stone MA, Appleton L, Moutsianis L, Leslie S, Wordsworth T, Kenna TJ, Karaderi T, Thomas GP, Ward MM, Weisman MH, Farrar C, Bradbury LA, Danoy P, Inman RD, Maksymowych W, Gladman D, Rahman P, Morgan A, Marzo-Ortega H, Bowness P, Gaffney K, et al: Interaction between ERAP1 and HLA-B27 in ankylosing spondylitis implicates peptide handling in the mechanism for HLA-B27 in disease susceptibility. Nat Genet. 2011, 43: 761-767. 10.1038/ng.873.PubMedCentralCrossRefPubMed
38.
go back to reference Strange A, Capon F, Spencer CC, Knight J, Weale ME, Allen MH, Barton A, Band G, Bellenguez C, Bergboer JG, Blackwell JM, Bramon E, Bumpstead SJ, Casas JP, Cork MJ, Corvin A, Deloukas P, Dilthey A, Duncanson A, Edkins S, Estivill X, Fitzgerald O, Freeman C, Giardina E, Gray E, Hofer A, Huffmeier U, Hunt SE, Irvine AD, Jankowski J, et al: A genome-wide association study identifies new psoriasis susceptibility loci and an interaction between HLA-C and ERAP1. Nat Genet. 2010, 42: 985-990. 10.1038/ng.694.PubMedCentralCrossRefPubMed Strange A, Capon F, Spencer CC, Knight J, Weale ME, Allen MH, Barton A, Band G, Bellenguez C, Bergboer JG, Blackwell JM, Bramon E, Bumpstead SJ, Casas JP, Cork MJ, Corvin A, Deloukas P, Dilthey A, Duncanson A, Edkins S, Estivill X, Fitzgerald O, Freeman C, Giardina E, Gray E, Hofer A, Huffmeier U, Hunt SE, Irvine AD, Jankowski J, et al: A genome-wide association study identifies new psoriasis susceptibility loci and an interaction between HLA-C and ERAP1. Nat Genet. 2010, 42: 985-990. 10.1038/ng.694.PubMedCentralCrossRefPubMed
39.
go back to reference Doodes PD, Cao Y, Hamel KM, Wang Y, Rodeghero RL, Mikecz K, Glant TT, Iwakura Y, Finnegan A: IFN-γ Regulates the Requirement for IL-17 in Proteoglycan-Induced Arthritis. J Immunol. 2010, 184: 1552-1559. 10.4049/jimmunol.0902907.PubMedCentralCrossRefPubMed Doodes PD, Cao Y, Hamel KM, Wang Y, Rodeghero RL, Mikecz K, Glant TT, Iwakura Y, Finnegan A: IFN-γ Regulates the Requirement for IL-17 in Proteoglycan-Induced Arthritis. J Immunol. 2010, 184: 1552-1559. 10.4049/jimmunol.0902907.PubMedCentralCrossRefPubMed
40.
go back to reference Boldizsar F, Tarjanyi O, Nemeth P, Mikecz K, Glant TT: Th1/Th17 polarization and acquisition of an arthritogenic phenotype in arthritis-susceptible BALB/c, but not in MHC-matched, arthritis-resistant DBA/2 mice. Int Immunol. 2009, 21: 511-522. 10.1093/intimm/dxp018.PubMedCentralCrossRefPubMed Boldizsar F, Tarjanyi O, Nemeth P, Mikecz K, Glant TT: Th1/Th17 polarization and acquisition of an arthritogenic phenotype in arthritis-susceptible BALB/c, but not in MHC-matched, arthritis-resistant DBA/2 mice. Int Immunol. 2009, 21: 511-522. 10.1093/intimm/dxp018.PubMedCentralCrossRefPubMed
41.
go back to reference Shen H, Goodall JC, Hill Gaston JS: Frequency and phenotype of peripheral blood Th17 cells in ankylosing spondylitis and rheumatoid arthritis. Arthritis Rheum. 2009, 60: 1647-1656. 10.1002/art.24568.CrossRefPubMed Shen H, Goodall JC, Hill Gaston JS: Frequency and phenotype of peripheral blood Th17 cells in ankylosing spondylitis and rheumatoid arthritis. Arthritis Rheum. 2009, 60: 1647-1656. 10.1002/art.24568.CrossRefPubMed
42.
go back to reference Kenna TJ, Davidson SI, Duan R, Bradbury LA, McFarlane J, Smith M, Weedon H, Street S, Thomas R, Thomas GP, Brown MA: Enrichment of circulating interleukin-17-secreting interleukin-23 receptor-positive γ/δ T cells in patients with active ankylosing spondylitis. Arthritis Rheum. 2012, 64: 1420-1429. 10.1002/art.33507.CrossRefPubMed Kenna TJ, Davidson SI, Duan R, Bradbury LA, McFarlane J, Smith M, Weedon H, Street S, Thomas R, Thomas GP, Brown MA: Enrichment of circulating interleukin-17-secreting interleukin-23 receptor-positive γ/δ T cells in patients with active ankylosing spondylitis. Arthritis Rheum. 2012, 64: 1420-1429. 10.1002/art.33507.CrossRefPubMed
43.
go back to reference Davidson SI, Liu Y, Danoy PA, Wu X, Thomas GP, Jiang L, Sun L, Wang N, Han J, Han H, Visscher PM, Brown MA, Xu H: Association of STAT3 and TNFRSF1A with ankylosing spondylitis in Han Chinese. Ann Rheum Dis. 2011, 70: 289-292. 10.1136/ard.2010.133322.CrossRefPubMed Davidson SI, Liu Y, Danoy PA, Wu X, Thomas GP, Jiang L, Sun L, Wang N, Han J, Han H, Visscher PM, Brown MA, Xu H: Association of STAT3 and TNFRSF1A with ankylosing spondylitis in Han Chinese. Ann Rheum Dis. 2011, 70: 289-292. 10.1136/ard.2010.133322.CrossRefPubMed
44.
go back to reference Chen C-H, Lin K-C, Yu DTY, Yang C, Huang F, Chen H-A, Liang T-H, Liao H-T, Tsai C-Y, Wei JCC, Chou C-T: Serum matrix metalloproteinases and tissue inhibitors of metalloproteinases in ankylosing spondylitis: MMP-3 is a reproducibly sensitive and specific biomarker of disease activity. Rheumatology. 2006, 45: 414-420. 10.1093/rheumatology/kei208.CrossRefPubMed Chen C-H, Lin K-C, Yu DTY, Yang C, Huang F, Chen H-A, Liang T-H, Liao H-T, Tsai C-Y, Wei JCC, Chou C-T: Serum matrix metalloproteinases and tissue inhibitors of metalloproteinases in ankylosing spondylitis: MMP-3 is a reproducibly sensitive and specific biomarker of disease activity. Rheumatology. 2006, 45: 414-420. 10.1093/rheumatology/kei208.CrossRefPubMed
45.
go back to reference Hayer S, Niederreiter B, Nagelreiter I, Smolen J, Redlich K: Interleukin 6 is not a crucial regulator in an animal model of tumour necrosis factor-mediated bilateral sacroiliitis. Ann Rheum Dis. 2010, 69: 1403-1406. 10.1136/ard.2010.129148.CrossRefPubMed Hayer S, Niederreiter B, Nagelreiter I, Smolen J, Redlich K: Interleukin 6 is not a crucial regulator in an animal model of tumour necrosis factor-mediated bilateral sacroiliitis. Ann Rheum Dis. 2010, 69: 1403-1406. 10.1136/ard.2010.129148.CrossRefPubMed
46.
go back to reference Appel H, Ruiz-Heiland G, Listing J, Zwerina J, Herrmann M, Mueller R, Haibel H, Baraliakos X, Hempfing A, Rudwaleit M, Sieper J, Schett G: Altered skeletal expression of sclerostin and its link to radiographic progression in ankylosing spondylitis. Arthritis Rheum. 2009, 60: 3257-3262. 10.1002/art.24888.CrossRefPubMed Appel H, Ruiz-Heiland G, Listing J, Zwerina J, Herrmann M, Mueller R, Haibel H, Baraliakos X, Hempfing A, Rudwaleit M, Sieper J, Schett G: Altered skeletal expression of sclerostin and its link to radiographic progression in ankylosing spondylitis. Arthritis Rheum. 2009, 60: 3257-3262. 10.1002/art.24888.CrossRefPubMed
Metadata
Title
Excessive bone formation in a mouse model of ankylosing spondylitis is associated with decreases in Wnt pathway inhibitors
Authors
Katelin R Haynes
Allison R Pettit
Ran Duan
Hsu-Wen Tseng
Tibor T Glant
Matthew A Brown
Gethin P Thomas
Publication date
01-12-2012
Publisher
BioMed Central
Published in
Arthritis Research & Therapy / Issue 6/2012
Electronic ISSN: 1478-6362
DOI
https://doi.org/10.1186/ar4096

Other articles of this Issue 6/2012

Arthritis Research & Therapy 6/2012 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.